Siyu Wang
Shenyang Pharmaceutical University
ORCID: 0000-0002-7603-2012Also affiliated with Allen Institute for Brain Science, Guiyang Medical University, Sun Yat-sen University, Tianjin University, Nanjing Forestry University, Shanxi Medical University, Capital Medical University, Heilongjiang University of Chinese Medicine, Anhui Medical University, Chinese Academy of Medical Sciences & Peking Union Medical College, Nankai University, Cornell University, Inner Mongolia University, Peking Union Medical College Hospital, Chinese PLA General Hospital, Southern University of Science and Technology, Wuhan University, Beijing Tian Tan Hospital, Sun Yat-sen Memorial Hospital, MIND Research Institute, Linyi People's Hospital, Zhejiang Cancer Hospital, Beijing Hospital, Taiyuan Central Hospital, Renmin Hospital of Wuhan University, Sun Yat-sen University Cancer Center, Dahua Technology (China), Shenzhen Technology University, Second People’s Hospital of Yibin, Chinese People's Liberation Army, Weill Cornell Medicine, State Key Laboratory of Oncology in South China, Shaanxi University of Chinese Medicine, Icahn School of Medicine at Mount Sinai
Pilot corpus only
This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.
Indexed papers
Papers
Driven by 6 papers. Top paper: “Human umbilical cord-derived mesenchymal stem cell therapy in patients with COVID-19: a phase 1 clinical trial”.
Ruonan Xu, Siyu Wang, Zhe Xu, Chao Zhang, Yuanyuan Li +19 more
Xue Xiao, Rui Duan, Pengyu Gong, Yan E, Teng Jiang +3 more
Melissa A. Musser, Gavin A. Kuziel, Min Liu, Amy Shepherd, Siyu Wang +13 more
Yuansong Wan, Tahsin Reaz Ahmed, Siyu Wang, Subodh Kumar Samrat, Zhong Li +4 more
Yuebao Zhang, Yichen Zhong, Kaiyuan Guo, Shi Du, Yonger Xue +15 more
Ravi Kumar Nagiri, Siyu Wang, Chloe S. Larson, Loreto Carvallo-Torres, Vipin Kumar Singh +4 more